211 - Since Jan 2009 Q&A, is there update further to question #84 on distribution of reprints and Health Canada/PAAB postiion?
-
The answer to question #84 has not changed. Health Canada is ever vigilant of off-label promotion and unsolicited distribution of reprints by pharma reps is a tactic that can do that. Therefore, the PAAB advises companies to train their reps well and restrict the materials they hand out, to those that meet the requirements of the federal law and the PAAB Code of Advertising Acceptance.
